Sarah Alrasheed: New Evidence on Transitioning From Parenteral Prostacyclin to Selexipag
Sarah Alrasheed, Associate Consultant in Pulmonary Medicine at King Faisal Specialist Hospital and Research Center, shared on LinkedIn:
“I am pleased to share that our latest research has been published in Pulmonary Circulation. In this study, we address a critical and sensitive clinical question: the transition from parenteral prostacyclin therapy to Selexipag.
Until now, many of us in clinical practice have had limited evidence to guide whether transitioning to oral prostacyclin pathway therapy is safe and feasible, and most importantly: what the safety implications of this decision are for our patients. Our findings aim to provide practical, real world guidance to support clinicians facing this complex decision.
I hope this work proves valuable for your practice and for the care of patients with pulmonary hypertension.
You can access the article here.”
Article: Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study
Authors: Brandon Budhram, Sarah K. Alrasheed, Moaaz Rashad, George Chandy, Anna Dvorkin-Gheva, George A. Fox, Julia Foxall, Andrea Gardner, Doug Helmersen, Naushad Hirani, Kristina Kemp, Mithum Kularatne, David Langleben, Lyda Lesenko, Steeve Provencher, Emma Spence, John R. Swiston, Mitesh Thakrar, Daniel Wadden, Jason Weatherald, Nathan Hambly
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings